opc 12759 has been researched along with amyloid beta-peptides in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukui, K; Hayakari, R; Imaizumi, T; Matsumiya, T; Tanaka, H; Tanji, K; Tsuruga, K; Yachi, K; Yoshida, H | 1 |
1 other study(ies) available for opc 12759 and amyloid beta-peptides
| Article | Year |
|---|---|
Rebamipide reduces amyloid-β 1-42 (Aβ42) production and ameliorates Aβ43-lowered cell viability in cultured SH-SY5Y human neuroblastoma cells.
Topics: Alanine; Alzheimer Disease; Amyloid beta-Peptides; Cell Line, Tumor; Cell Survival; Cyclooxygenase 2; Gene Expression; Humans; Neurons; Peptide Fragments; Quinolones; Sirtuin 1 | 2017 |